Sanofi's Revolutionary Blood Cancer Drug: A Breakthrough in Wearable Injection Technology
Published on: July 11, 2026, 6:30 p.m. | Source: Devdiscourse
The U.S. FDA has approved Sanofi's Sarclisa, a blood cancer drug, in a groundbreaking wearable form to aid multiple myeloma patients, providing an alternative to intravenous infusions. This marks the first FDA-approved cancer drug delivery via an on-body injector, making cancer treatment less burdensome.
